Renalytix (Reg S) (RENX) RNS Announcements

Add to Alert list
Date Time Source Announcement
12 Jun 2020 07:00 AM
RNS
KidneyIntelXT receives New York State approval
10 Jun 2020 08:00 AM
RNS
Confirmation of reduction of capital
10 Jun 2020 07:00 AM
RNS
Positive results of clinical validation study
20 May 2020 11:06 AM
RNS
Second Price Monitoring Extn
20 May 2020 11:00 AM
RNS
Price Monitoring Extension
20 May 2020 07:00 AM
RNS
JV for COVID-19 antibody test scaled production
18 May 2020 07:00 AM
RNS
Proposed dual-listing on Nasdaq
15 May 2020 01:02 PM
RNS
Result of General Meeting
05 May 2020 10:55 AM
RNS
Removal of US Securities Law Restrictions
28 Apr 2020 07:00 AM
RNS
Update re. potential demerger of FractalDx
27 Apr 2020 07:00 AM
RNS
Utah Lab Facility Achieves ISO 13485 Certification
20 Apr 2020 07:00 AM
RNS
KidneyIntelX used in Mount Sinai COVID-19 study
15 Apr 2020 07:00 AM
RNS
Provider network agreement for KidneyIntelXT
01 Apr 2020 07:00 AM
RNS
Medicare provider number
27 Mar 2020 10:32 AM
RNS
Holding(s) in Company
27 Mar 2020 07:00 AM
RNS
Presentation of KidneyIntelX Health Economics Data
24 Mar 2020 07:00 AM
RNS
Podium Presentation and Publication for Data
03 Mar 2020 07:00 AM
RNS
Half-year Report
26 Feb 2020 07:00 AM
RNS
Notice of Results
25 Feb 2020 07:00 AM
RNS
Conference attendance
08 Jan 2020 07:00 AM
RNS
New commercial testing facility opens in Utah
03 Jan 2020 07:00 AM
RNS
CMS Pricing Determination becomes effective
03 Dec 2019 07:00 AM
RNS
Medicare sets US national price for KidneyIntelX
21 Nov 2019 07:00 AM
RNS
Grant of Options
19 Nov 2019 07:00 AM
RNS
RenalytixAI attending City Event for Kidney Health
17 Oct 2019 07:00 AM
RNS
Partnership with CDPHP on KidneyIntelX
14 Oct 2019 07:00 AM
RNS
Board appointment
01 Oct 2019 07:00 AM
RNS
US CPT® reimbursement code effective
30 Sep 2019 04:37 PM
RNS
Result of AGM
30 Sep 2019 08:00 AM
RNS
Update on non-executive director appointment
30 Sep 2019 07:00 AM
RNS
Preliminary Medicare Pricing Determination
06 Sep 2019 04:00 PM
RNS
Posting of Annual Report & Accounts &Notice of AGM
03 Sep 2019 07:00 AM
RNS
Final Results
20 Aug 2019 07:00 AM
RNS
Notice of Results
06 Aug 2019 07:00 AM
RNS
Expansion of Chronic Kidney Disease Advisory Board
31 Jul 2019 04:30 PM
RNS
Total Voting Rights
29 Jul 2019 07:00 AM
RNS
Thomas McLain Appointed as President and CCO
23 Jul 2019 06:23 PM
RNS
Result of Placing & Total Voting Rights
23 Jul 2019 07:01 AM
RNS
Proposed Placing to raise £12.0m (c.US$15.0m)
12 Jul 2019 07:00 AM
RNS
US Exec Order on Advancing American Kidney Health
09 Jul 2019 07:00 AM
RNS
Positive Interim Results for Validation Study
08 Jul 2019 07:00 AM
RNS
FractalDx Positive Results Published in JASN
01 Jul 2019 07:00 AM
RNS
US CPT® Code Granted for KidneyIntelX(TM)
07 Jun 2019 07:00 AM
RNS
Positive results from FractalDx study published
04 Jun 2019 07:00 AM
RNS
KidneyIntelX commercial scale production milestone
28 May 2019 07:00 AM
RNS
CLIA Certificate Number issued for Renalytix Lab
21 May 2019 07:00 AM
RNS
Expansion of FractalDx core investigator group
07 May 2019 07:00 AM
RNS
University Medical Center Groningen collaboration
02 May 2019 02:05 PM
RNS
Second Price Monitoring Extn
02 May 2019 02:00 PM
RNS
Price Monitoring Extension

Renalytix is an artificial intelligence-enabled in vitro diagnostics company which focuses on kidney disease

Renalytics share price launched at 120p in 2018.

UK 100

Latest directors dealings